UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026553
Receipt number R000030442
Scientific Title Safety study of neural repair surgery using platelet-rich plasma for peripheral nerve injury
Date of disclosure of the study information 2017/04/01
Last modified on 2017/03/14 18:15:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety study of neural repair surgery using platelet-rich plasma for peripheral nerve injury

Acronym

Nerve repair surgery using platelet-rich plasma

Scientific Title

Safety study of neural repair surgery using platelet-rich plasma for peripheral nerve injury

Scientific Title:Acronym

Nerve repair surgery using platelet-rich plasma

Region

Japan


Condition

Condition

Peripheral nerve injury

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the safety and effect of the use of platelet-rich plasma

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

Safety of the use of platelet-rich plasma for nerve repair surgery

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Local administration of platelet-rich plasma for nerve repair site and graft site

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

peripheral nerve injury patient who needs nerve repair surgery

Key exclusion criteria

Infection, Immunodeficiency, Autoimmune disease, Anemia, Blood disease, Anticoagulant use, Steroid treatment within 3 months, Malignancy within 5 years, Not agreed, Unable to make an agreement under written document, Not appropriate for the study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuki Hara

Organization

University of Tsukuba

Division name

Faculty of medicine, department of orthopedic surgery

Zip code


Address

1-1-1, Tennoudai, Tsukuba, Ibaraki

TEL

029-853-3219

Email

yukihara@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuki Hara

Organization

University of Tsukuba

Division name

Faculty of medicine, department of orthopedic surgery

Zip code


Address

1-1-1, Tennoudai, Tsukuba, Ibaraki

TEL

029-853-3219

Homepage URL


Email

yukihara@md.tsukuba.ac.jp


Sponsor or person

Institute

Univerisity of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the promotion of sciences

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波大学附属病院(茨城県)


Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2017 Year 02 Month 22 Day

Date of IRB


Anticipated trial start date

2017 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 03 Month 14 Day

Last modified on

2017 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030442